Transarterial chemoembolization (TACE) does have little impact on hepatic metabolic function in patients with hepatocelluar carcinoma (HCC)

Autor:	Patrick Stuebs, Konrad Mohnike, Peter Malfertheiner, Jan Bornschein, O. Milbradt, K. Schuette
Rok vydání:	2011
Předmět:	Cancer Research medicine.medical_specialty Metabolic function Cirrhosis business.industry Impaired liver function medicine.disease Gastroenterology Oncology Internal medicine medicine In patient business Selection (genetic algorithm) Hepatocelluar carcinoma
Zdroj:	Journal of Clinical Oncology. 29:e14527-e14527
ISSN:	1527-7755 0732-183X
Popis:	e14527 Background: 70-90% of patients with HCC suffer from liver cirrhosis. A high proportion present with impaired liver function which is critical for the selection of treatment. Locoregional the...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::81a6dd05ea3c03c8782de0fc95cf6328 https://doi.org/10.1200/jco.2011.29.15_suppl.e14527 Zobrazit plný text záznamu